• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Microfluidics device captures circulating cancer cell clusters

Bioengineer by Bioengineer
June 18, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new tool will help cancer researchers gain a better understanding of the critical mechanisms at play during metastasis.

IMAGE

Credit: Shaner et al.

WASHINGTON, D.C., June 18, 2019 — Cancer touches nearly everyone in one way or another, and regrettably, it will claim another 600,000 lives in the U.S. in 2019, according to the American Cancer Society. Researchers from San Diego State University, TumorGen MDx Inc., and Sanford Burnham Prebys Medical Discovery Institute set out to explore a seemingly basic question: What is it about cancer that kills?

The answer is, about 90% of cancer deaths are due to metastases, when tumors spread to other vital organs. How does cancer metastasize? After an exhaustive search of the scientific literature, the researchers realized that it’s not individual cells but rather distinct clusters of cancer cells that circulate and metastasize to other organs.

As the group reports in AIP Advances, from AIP Publishing, this caused them to question — if these cell clusters are the “root causes of cancer,” why isn’t more research being devoted to gaining a better understanding of circulating cancer cell clusters?

“The reason for such little research activity is the overwhelming difficulty of capturing these extremely rare metastatic cancer cell clusters from a patient’s blood sample,” said Peter Teriete, one of the authors and a research assistant professor at Sanford Burnham Prebys Medical Discovery Institute. “But we realized that if we’re ever going to understand the complex process of cancer metastasis, we’d need to develop a tool to easily find these clusters.”

To do this, the researchers first identified the basic requirements essential to collecting useful information from isolated cancer cell clusters. It involves a sample size large enough to likely contain appreciable numbers of cancer cell clusters (about 10 milliliters of whole blood), as well as using whole blood to preserve rare circulating clusters. Whole blood, however, requires channel-coating procedures that reduce nonspecific binding properties to prevent biofouling. And the device channel dimensions must be of a suitable size to accommodate single cells and cancer cell clusters of varying diameters.

“Our device’s channel design had to generate microfluidic flow characteristics suitable to facilitate cell capture via antibodies within the coated channels,” Teriete explained. “So we introduced microfeatures — herringbone recesses — to produce the desired functionality. We also developed a unique alginate hydrogel coating that can be readily decorated with antibodies or other biomolecules. By connecting bioengineering with materials science and basic cancer biology, we were able to develop a device and prove that it performs as desired.”

The group’s microfluidic device brings a new therapeutic strategy to the fight against cancer metastasis. Capturing viable circulating cancer stem cell clusters directly from cancer patients is a novel approach for the development of new anti-metastatic drug therapies.

“Drug development that specifically targets distant metastases has been greatly restricted due to the lack of adequate tools that can readily access the metastatic cells responsible for cancer’s dissemination,” said Teriete. “Our microfluidic device will provide cancer researchers with actual human cancer cell clusters, so they can begin to understand the critical mechanisms involved with metastasis and develop highly effective drugs that ultimately can save more cancer patients’ lives.”

###

The article, “Design and production of a novel microfluidic device for the capture and isolation of circulating tumor cell clusters,” is authored by Sebastian W. Shaner, Jeffrey K. Allen, Martina Felderman, Evan T. Pasko, Carina D. Wimer, Nicholas D.P Cosford, Samuel Kassegne and Peter Teriete. It appears in AIP Advances on June 18, 2019 (DOI: 10.1063/1.5084736) and can be accessed at http://aip.scitation.org/doi/full/10.1063/1.5084736.

ABOUT THE JOURNAL

AIP Advances is a fully open access, online-only, peer-reviewed journal. It covers all areas of applied physical sciences. With its advanced web 2.0 functionality, the journal puts relevant content and discussion tools in the hands of the community to shape the direction of the physical sciences. See http://aipadvances.aip.org.

Media Contact
Larry Frum
[email protected]

Related Journal Article

http://dx.doi.org/10.1063/1.5084736

Tags: BiologyBiomechanics/BiophysicsBiomedical/Environmental/Chemical EngineeringBiotechnologycancerCell BiologyChemistry/Physics/Materials SciencesMedicine/HealthTechnology/Engineering/Computer Science
Share12Tweet8Share2ShareShareShare2

Related Posts

TPMT Expression Predictions Linked to Azathioprine Side Effects

February 7, 2026

Improving Dementia Care with Enhanced Activity Kits

February 7, 2026

Decoding Prostate Cancer Origins via snFLARE-seq, mxFRIZNGRND

February 7, 2026

Digital Health Perspectives from Baltic Sea Experts

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

TPMT Expression Predictions Linked to Azathioprine Side Effects

Improving Dementia Care with Enhanced Activity Kits

Decoding Prostate Cancer Origins via snFLARE-seq, mxFRIZNGRND

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.